Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4244582
Max Phase: Preclinical
Molecular Formula: C13H10O5
Molecular Weight: 246.22
Molecule Type: Small molecule
Associated Items:
ID: ALA4244582
Max Phase: Preclinical
Molecular Formula: C13H10O5
Molecular Weight: 246.22
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc(-c2ccc(C=O)o2)ccc1C(=O)O
Standard InChI: InChI=1S/C13H10O5/c1-17-12-6-8(2-4-10(12)13(15)16)11-5-3-9(7-14)18-11/h2-7H,1H3,(H,15,16)
Standard InChI Key: IQZDKOJUOMOHCJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 246.22 | Molecular Weight (Monoisotopic): 246.0528 | AlogP: 2.47 | #Rotatable Bonds: 4 |
Polar Surface Area: 76.74 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.55 | CX Basic pKa: | CX LogP: 1.81 | CX LogD: -1.55 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.84 | Np Likeness Score: -0.09 |
1. Moya-Garzón MD, Martín Higueras C, Peñalver P, Romera M, Fernandes MX, Franco-Montalbán F, Gómez-Vidal JA, Salido E, Díaz-Gavilán M.. (2018) Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1., 61 (16): [PMID:30028141] [10.1021/acs.jmedchem.8b00399] |
Source(1):